Citi analyst Daniel Grosslight reiterated a Buy rating and $16.00 price target on Hims and Hers (NYSE: HIMS)The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Hims and Hers (HIMS) PT Raised to $24 at Canaccord GenuityMay 22, 2024 5:29 AM Hims & Hers Health (HIMS) Announces Access to GLP-1 InjectionsMay 20, 2024 9:01 AM Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto CustomersMay 20, 2024 9:00 AM Midday movers: Nvidia, Micron and Wix rise; Li Auto fallsMay 20, 2024 7:41 AM Form 144 Hims & Hers Health, Inc. Filed by: Becklund IreneMay 17, 2024 12:20 PM Hims & Hers Health (HIMS) Appoints Anja Manuel to its BoardMay 16, 2024 6:02 AM Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of DirectorsMay 16, 2024 6:00 AM